Search Login Register
Angiotensin II
Summary
Description:
An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.
Also Known As:
5-L-Isoleucine Angiotensin II; ANG-(1-8)Octapeptide; Angiotensin II, Isoleucine(5)-; Angiotensin II, Valine(5)-; Angiotensin-(1-8) Octapeptide Show All >>
Networked: 10133
relevant articles (315 outcomes,
1327 trials/studies)
for this Bio-Agent
Key Diseases for which Angiotensin II is
Relevant
-
Hypertension (High Blood Pressure)
:
96 outcomes 366 studies in 2941 results
-
Heart Failure
:
29 outcomes 83 studies in 647 results
-
Fibrosis (Cirrhosis)
:
22 outcomes 85 studies in 691 results
-
Cardiomegaly (Heart Hypertrophy)
:
14 outcomes 56 studies in 456 results
-
Diabetic Nephropathies (Diabetic Nephropathy)
:
14 outcomes 55 studies in 193 results
Show All >>
Drugs Related to Angiotensin II
-
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
-
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
-
Losartan (Cozaar)
-
Renin
-
Captopril (Capoten)
-
Angiotensin Receptor Antagonists
-
Aldosterone
-
Norepinephrine (Noradrenaline)
-
Sodium
-
Insulin (Novolin)
Show All >>
Therapies Related to Angiotensin II
-
Drug Therapy (Chemotherapy)
-
Transplants (Transplant)
-
Intra-Arterial Infusions
-
Injections
-
Microspheres (Microsphere)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.